Weekly shot may help 'double diabetes' patients control blood sugar
NCT ID NCT05305794
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a weekly injection of semaglutide (a GLP-1 drug) in 76 adults with 'double diabetes' — a mix of type 1 diabetes and inherited insulin resistance. The goal is to see if the drug improves blood sugar control and helps with weight loss. Participants must be over 18, have type 1 diabetes, a BMI of 27 or higher, and a family history of type 2 diabetes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DOUBLE DIABETES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Chu Dijon Bourgogne
RECRUITINGDijon, 21000, France